CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 442 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02638220
NCT02638220N/ACompleted

An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts

Travere Therapeutics, Inc.·observational·Posted Dec 23, 2015·Updated Sep 19, 2024

In Brief

An observational study for Cerebrotendinous Xanthomatosis (CTX). Completed, enrolled 442 participants across 44 sites.

Detailed Summary

Iiopathic bilateral cataracts occur in many children with Cerebrotendinous Xanthomatosis (CTX) so the opportunity to use contact with health care providers in connection with pediatric cataract evaluation and treatment is a promising avenue for disease detection and prevention.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 23, 2015
Enrollment StartSep 1, 2015
Primary CompletionFeb 19, 2021
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 10.5 years ago